Advertisement
Small Pharma, a small Canadian start-up that is modifying the psychedelic DMT to treat depression, recently revealedfrom a study that failed to excite investors. “These results are extremely promising but they had no effect on the share price, zero,” said Jan Hardorp, a founding partner at venture capital firm re.Mind Capital that has invested in the company.
“I remember looking at it thinking, like, ‘That can’t be real, it’s too good,’” he recalled in an interview.these days leading a revolution in artificial intelligence, helming the firm that mesmerized and unnerved much of the public with the release of a chatbot that could, at a prompt, churn out humanlike text. But he still sees unrealized potential in psychedelics and eagerly backed Journey’s mission.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
ChatGPT and Generative AI in Payments: How to PrepareInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Jobs, pay for college-educated workers will be changed most by AI like ChatGPTAI like ChatGPT could change the day-to-day of white-collar jobs the most and reverse decades of tech-driven inequality — if we use it the right way
Source: BusinessInsider - 🏆 729. / 51 Read more »